PulseAugur
EN
LIVE 18:11:43

AI detects toxicity in preclinical histopathology using novel anomaly detection

Researchers have developed an AI framework to detect toxicity in preclinical histopathology using whole-slide images. This system can identify healthy tissue, known pathologies, and flag samples with novel anomalies. By fine-tuning a Vision Transformer with Low-Rank Adaptation and employing Mahalanobis distance for anomaly detection, the method aims to improve the efficiency and scale of toxicity assessment in drug development. AI

IMPACT Could accelerate preclinical drug development by automating toxicity assessment in histopathology.

RANK_REASON Research paper detailing a novel AI method for toxicity assessment in histopathology. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.AI →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI detects toxicity in preclinical histopathology using novel anomaly detection

COVERAGE [1]

  1. arXiv cs.AI TIER_1 English(EN) · Olga Graf, Dhrupal Patel, Peter Gro{\ss}, Charlotte Lempp, Matthias Hein, Fabian Heinemann ·

    Toxicity Assessment in Preclinical Histopathology via Class-Aware Mahalanobis Distance for Known and Novel Anomalies

    arXiv:2602.02124v2 Announce Type: replace-cross Abstract: Drug-induced toxicity is a leading cause of preclinical and early-clinical failure, making early detection critical. Histopathology is the gold standard for toxicity assessment but relies on expert pathologists, creating a…